183 related articles for article (PubMed ID: 19112075)
1. Epidemiology and cost of treatment of genital warts in Spain.
Castellsagué X; Cohet C; Puig-Tintoré LM; Acebes LO; Salinas J; San Martin M; Breitscheidel L; Rémy V
Eur J Public Health; 2009 Jan; 19(1):106-10. PubMed ID: 19112075
[TBL] [Abstract][Full Text] [Related]
2. Economic burden associated with the management of cervical cancer, cervical dysplasia and genital warts in Belgium.
Annemans L; Rémy V; Lamure E; Spaepen E; Lamotte M; Muchada JP; Largeron N
J Med Econ; 2008; 11(1):135-50. PubMed ID: 19450115
[TBL] [Abstract][Full Text] [Related]
3. [Anogenital warts incidence, medical management and costs in women consulting gynaecologists in France].
Monsonégo J; Breugelmans JG; Bouée S; Lafuma A; Bénard S; Rémy V
Gynecol Obstet Fertil; 2007 Feb; 35(2):107-13. PubMed ID: 17270482
[TBL] [Abstract][Full Text] [Related]
4. Genital warts incidence and healthcare resource utilisation in Australia.
Pirotta M; Stein AN; Conway EL; Harrison C; Britt H; Garland S
Sex Transm Infect; 2010 Jun; 86(3):181-6. PubMed ID: 19965802
[TBL] [Abstract][Full Text] [Related]
5. Natural history of genital warts: analysis of the placebo arm of 2 randomized phase III trials of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine.
Garland SM; Steben M; Sings HL; James M; Lu S; Railkar R; Barr E; Haupt RM; Joura EA
J Infect Dis; 2009 Mar; 199(6):805-14. PubMed ID: 19199546
[TBL] [Abstract][Full Text] [Related]
6. Estimation of the incidence of genital warts and the cost of illness in Germany: a cross-sectional study.
Hillemanns P; Breugelmans JG; Gieseking F; Bénard S; Lamure E; Littlewood KJ; Petry KU
BMC Infect Dis; 2008 Jun; 8():76. PubMed ID: 18518976
[TBL] [Abstract][Full Text] [Related]
7. Assessing incidence and economic burden of genital warts with data from a US commercially insured population.
Hoy T; Singhal PK; Willey VJ; Insinga RP
Curr Med Res Opin; 2009 Oct; 25(10):2343-51. PubMed ID: 19650749
[TBL] [Abstract][Full Text] [Related]
8. Costs of detection and treatment of cervical cancer, cervical dysplasia and genital warts in the UK.
Brown RE; Breugelmans JG; Theodoratou D; Bénard S
Curr Med Res Opin; 2006 Apr; 22(4):663-70. PubMed ID: 16684427
[TBL] [Abstract][Full Text] [Related]
9. Determining the cost of genital warts: a study from Ireland.
Dee A; Howell F; O'Connor C; Cremin S; Hunter K
Sex Transm Infect; 2009 Sep; 85(5):402-3. PubMed ID: 19004863
[TBL] [Abstract][Full Text] [Related]
10. The economic impact of overactive bladder syndrome in six Western countries.
Irwin DE; Mungapen L; Milsom I; Kopp Z; Reeves P; Kelleher C
BJU Int; 2009 Jan; 103(2):202-9. PubMed ID: 19278532
[TBL] [Abstract][Full Text] [Related]
11. Chapter 4: Burden and management of non-cancerous HPV-related conditions: HPV-6/11 disease.
Lacey CJ; Lowndes CM; Shah KV
Vaccine; 2006 Aug; 24 Suppl 3():S3/35-41. PubMed ID: 16950016
[TBL] [Abstract][Full Text] [Related]
12. Incidence of genital warts in Sweden before and after quadrivalent human papillomavirus vaccine availability.
Leval A; Herweijer E; Arnheim-Dahlström L; Walum H; Frans E; Sparén P; Simard JF
J Infect Dis; 2012 Sep; 206(6):860-6. PubMed ID: 22815381
[TBL] [Abstract][Full Text] [Related]
13. Treatment patterns and associated costs for genital warts in Italy.
Merito M; Largeron N; Cohet C; Timelli L; Boselli F; Matteelli A; Naldi L; Vittori G
Curr Med Res Opin; 2008 Nov; 24(11):3175-83. PubMed ID: 18851777
[TBL] [Abstract][Full Text] [Related]
14. Annual disease burden due to human papillomavirus (HPV) 6 and 11 infections in Finland.
Syrjänen KJ
Scand J Infect Dis Suppl; 2009; 107():3-32. PubMed ID: 19408160
[TBL] [Abstract][Full Text] [Related]
15. Estimation of the impact of genital warts on health-related quality of life.
Woodhall S; Ramsey T; Cai C; Crouch S; Jit M; Birks Y; Edmunds WJ; Newton R; Lacey CJ
Sex Transm Infect; 2008 Jun; 84(3):161-6. PubMed ID: 18339658
[TBL] [Abstract][Full Text] [Related]
16. The near disappearance of genital warts in young women 4 years after commencing a national human papillomavirus (HPV) vaccination programme.
Read TR; Hocking JS; Chen MY; Donovan B; Bradshaw CS; Fairley CK
Sex Transm Infect; 2011 Dec; 87(7):544-7. PubMed ID: 21970896
[TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus genotypes in genital warts in Latin America: a cross-sectional study in Bogota, Colombia.
Hernandez-Suarez G; Pineros M; Vargas JC; Orjuela L; Hernandez F; Peroza C; Torres D; Escobar A; Perez G
Int J STD AIDS; 2013 Jul; 24(7):567-72. PubMed ID: 23970773
[TBL] [Abstract][Full Text] [Related]
18. The health and economic burden of genital warts in a set of private health plans in the United States.
Insinga RP; Dasbach EJ; Myers ER
Clin Infect Dis; 2003 Jun; 36(11):1397-403. PubMed ID: 12766834
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology and costs associated with genital warts in Canada.
Marra F; Ogilvie G; Colley L; Kliewer E; Marra CA
Sex Transm Infect; 2009 Apr; 85(2):111-5. PubMed ID: 18981170
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus, genital warts, and vaccines.
Hsueh PR
J Microbiol Immunol Infect; 2009 Apr; 42(2):101-6. PubMed ID: 19597640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
